A case report of steriod induced cataract
Abstract
Prolonged use of glucocorticoids is a significant risk factor for the development of posterior subcapsular cataract. This places restrictions on the use of glucocorticoids in the treatment of systemic andor ocular inflammatory conditions as well as in organ transplantation. Steroid-induced posterior subcapsular cataracts (PSCs) exhibit three main distinctive characteristics (i) association only with steroids possessing glucocorticoid activity, (ii) involvement of aberrant migrating lens epithelial cells, and (iii) a central posterior location
Full Text:
PDFReferences
Thylefors B, NCgrel AD, PararajasegaramR, Dadzie W, Global data on blindness. Bull W O 1995; 73: 115121
Harding J, ed. Cataract: BiochemistryEpidemiology and Pharmacology. London: M Chapman and Hall, 1991; 83-124.
Urban RC Jnr, Cotlier E. Corticosteroidinduced cataracts. Sun, Ophthalmol1986; 31:102-110.
Oglesby RB, Black RL, von Sallmann L, Bunim JJ. Cataracts in rheumatoid arthritispatients treated with corticosteroids. Arch Ophthalmoll961; 66: 519-523.
Crews SJ. Posterior subcapsular lens opacities in patients on long-term corticosteroidtherapy. Br Med J 1963; 5346: 16441647.
Fryer JP, Granger DK, Leventhal JR,Gillingham K, Najarian JS, Matas AJ.Steroidrelated complications in the cyclosporine era. Clin Transplant 1994; 8:224229
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An Initiative of The Tamil Nadu Dr MGR Medical University